Skip To Content

Study ID: Merck MK-3475-177 Keynote 177 Colorectal

Title:

Phase III Study of Pembrolizumab vs Chemotherapy in Microsatellite Instability- High or Mismatched Repair Deficient Colorectal Carcinoma

Location:
Sioux Falls Region
Principal Investigator:
Jonathan Bleeker, MD
Disease:
Colorectal
Stage:
Phase III
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.